Share on StockTwits

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) SVP David J. Marguglio sold 4,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $5.56, for a total value of $22,240.00. Following the transaction, the senior vice president now directly owns 202,354 shares of the company’s stock, valued at approximately $1,125,088. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) traded up 3.49% on Friday, hitting $5.485. 16,475 shares of the company’s stock traded hands. Adamis Pharmaceuticals Corp has a 1-year low of $3.40 and a 1-year high of $11.90. The stock’s 50-day moving average is $5.85 and its 200-day moving average is $6.2. The company’s market cap is $57.4 million.

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), formerly Cellegy Pharmaceuticals, Incoperates through its wholly owned subsidiaries Cellegy Holdings, Inc, Adamis Corporation and Biosyn, Inc Adamis Corporation has two wholly owned subsidiaries: Adamis Viral Therapies, Inc (Adamis Viral) and Adamis Laboratories, Inc (Adamis Labs).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.